186 related articles for article (PubMed ID: 24118341)
1. Reciprocal effects of Interferon-γ and IL-4 on differentiation to osteoclast-like cells by RANKL or LPS.
Hu Y; Ek-Rylander B; Wendel M; Andersson G
Oral Dis; 2014 Oct; 20(7):682-92. PubMed ID: 24118341
[TBL] [Abstract][Full Text] [Related]
2. Locally administered interferon-γ accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation.
Ayon Haro ER; Ukai T; Yokoyama M; Kishimoto T; Yoshinaga Y; Hara Y
J Periodontal Res; 2011 Jun; 46(3):361-73. PubMed ID: 21361961
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory cytokines in mouse placental extracts inhibit in vitro osteoclast differentiation of murine macrophages.
Canellada A; Custidiano A; Abraham F; Rey E; Gentile T
Placenta; 2013 Mar; 34(3):231-9. PubMed ID: 23347887
[TBL] [Abstract][Full Text] [Related]
5. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells.
Kats A; Norgård M; Wondimu Z; Koro C; Concha Quezada H; Andersson G; Yucel-Lindberg T
J Cell Mol Med; 2016 Jun; 20(6):1128-38. PubMed ID: 26987561
[TBL] [Abstract][Full Text] [Related]
6. Anti-IFN-γ Antibody Promotes Osteoclastogenesis in Human Bone Marrow Monocyte-Derived Macrophages Co-Cultured with Tuberculosis-Activated Th1 Cells.
Deng J; Sun D; Luo F; Zhang Q; Chen F; Xu J; Zhang Z
Cell Physiol Biochem; 2018; 49(4):1512-1522. PubMed ID: 30205409
[TBL] [Abstract][Full Text] [Related]
7. Dual modulation of osteoclast differentiation by lipopolysaccharide.
Zou W; Bar-Shavit Z
J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
[TBL] [Abstract][Full Text] [Related]
9. WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.
Chen C; Qin Y; Fang JP; Ni XY; Yao J; Wang HY; Ding K
Acta Pharmacol Sin; 2015 Sep; 36(9):1053-64. PubMed ID: 26299951
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
[TBL] [Abstract][Full Text] [Related]
11. Lipoteichoic Acid of Enterococcus faecalis Inhibits the Differentiation of Macrophages into Osteoclasts.
Yang J; Park OJ; Kim J; Baik JE; Yun CH; Han SH
J Endod; 2016 Apr; 42(4):570-4. PubMed ID: 26920932
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide FF attenuates RANKL-induced differentiation of macrophage-like cells into osteoclast-like cells.
Sun Y; Chen X; Chen Z; Ma X; Li D; Shang P; Qian A
Arch Oral Biol; 2015 Feb; 60(2):282-92. PubMed ID: 25463906
[TBL] [Abstract][Full Text] [Related]
13. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
14. Activation of the liver X receptor-β potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages.
Robertson Remen KM; Lerner UH; Gustafsson JÅ; Andersson G
J Leukoc Biol; 2013 Jan; 93(1):71-82. PubMed ID: 23099324
[TBL] [Abstract][Full Text] [Related]
15. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells.
Pang M; Martinez AF; Jacobs J; Balkan W; Troen BR
Biochem Biophys Res Commun; 2005 Mar; 328(3):756-63. PubMed ID: 15694411
[TBL] [Abstract][Full Text] [Related]
16. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
17. Monosodium Urate in the Presence of RANKL Promotes Osteoclast Formation through Activation of c-Jun N-Terminal Kinase.
Choe JY; Park KY; Kim SK
Mediators Inflamm; 2015; 2015():597512. PubMed ID: 26347587
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells.
Hou GQ; Guo C; Song GH; Fang N; Fan WJ; Chen XD; Yuan L; Wang ZQ
Int J Mol Med; 2013 Aug; 32(2):503-10. PubMed ID: 23740407
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration.
Voronov I; Heersche JN; Casper RF; Tenenbaum HC; Manolson MF
Biochem Pharmacol; 2005 Jul; 70(2):300-7. PubMed ID: 15919055
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice.
Hayashi S; Tsuneto M; Yamada T; Nose M; Yoshino M; Shultz LD; Yamazaki H
Endocrinology; 2004 Jun; 145(6):2721-9. PubMed ID: 14988381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]